Summary of schedule of procedures for control group
| Peanut OIT; intervention group | |||||
| Study phase | Screening | Standard care | End of treatment | End of study | |
| Week of study | Up to −24 | 0–52 | 52 (up to 56) | +4 from EOT | |
| Visit category | Screening visit | Entry OFC | Telephone contact every 3 months | Exit OFC | |
| Duration | 2 hours | 5–6 hours | 15 min remote | 5–6 hours | 15 min remote |
| Procedure | |||||
| Informed consent | X | ||||
| Eligibility criteria | X | X | |||
| Demographics, medical and family history | X | ||||
| Anthropometrics, vital signs, physical exam, SCORAD | X | X | X | ||
| Questionnaires | X | X—12 weeks and 24 weeks | X | ||
| Skin prick test | X | X | |||
| Blood, stool and saliva samples | X | (X) | X | ||
| Oral food challenge | X | X | |||
| Adverse event, concomitant medication assessment | X | X | X | X | |
| Anaphylaxis education | X | X | |||
| Strict peanut avoidance | X | ||||
EOT, end of treatment; OFC, oral food challenge; OIT, oral immunotherapy; SCORAD, SCORing of Atopic Dermatitis.